Parmax Pharma Limited (BOM:540359)
104.87
+2.04 (1.98%)
At close: Jul 27, 2026
174.31% (1Y)
| Market Cap | 400.17M +179.8% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 3.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 109,947 |
| Open | 100.78 |
| Previous Close | 102.83 |
| Day's Range | 100.78 - 104.88 |
| 52-Week Range | 22.60 - 109.20 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |